Citizens Financial Group Free cash flow decreased by 85.7% to $237.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 204.4%, from -$227.00M to $237.00M. Over 3 years (FY 2021 to FY 2024), Free cash flow shows a downward trend with a -4.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $558.00M | $1.25B | $1.04B | $1.50B | -$1.88B | $2.92B | $1.46B | $1.10B | $83.00M | $982.00M | $622.00M | $544.00M | $804.00M | $96.00M | $435.00M | -$227.00M | $853.00M | $1.66B | $237.00M |
| QoQ Change | — | +124.6% | -17.0% | +44.5% | -225.1% | +255.0% | -50.1% | -24.3% | -92.5% | >999% | -36.7% | -12.5% | +47.8% | -88.1% | +353.1% | -152.2% | +475.8% | +94.7% | -85.7% |
| YoY Change | — | — | — | — | -437.1% | +132.6% | +40.0% | -26.7% | +104.4% | -66.3% | -57.3% | -50.6% | +868.7% | -90.2% | -30.1% | -141.7% | +6.1% | >999% | +204.4% |